Business / Finance

RSS

Medigus announces CMS’ publication of fee schedules for endoscopic fundoplication procedures under CPT code 43210 effective January 2016

Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that following the American Medical Association’s (AMA) decision earlier this year to create a new Category I Current Procedural Terminology (CPT®) code for esophagogastric fundoplast...

3 Nov 2015

Denator forms a new Scientific Advisory Board

Denator AB has announced that a new external expert advisory board has been formed. Karsten Fjärstedt, recently appointed as CEO comments, “It is a great honor for me to be entrusted to lead Denator forward in this new phase of development. With a pipeline of new exciting business opportunities and a strong Scientific Advisory Board (SAB) I am looking forward to realizing the full potential of the company technology”.

3 Nov 2015

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).

3 Nov 2015

Digital health startup boot camp expands to US

Startupbootcamp, a global family of industry - focused accelerators, has today announced the launch of its first accelerator programs in North America, Startupbootcamp Digital Health.

3 Nov 2015

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.

3 Nov 2015

Addus HomeCare’s net service revenues increase 3.3% to $84.3 million in Q3 2015

Addus HomeCare Corporation, a comprehensive provider of home and community-based services that are primarily personal in nature, provided in the home and focused on the dual eligible population, today announced its financial results for the third quarter and nine months ended September 30, 2015.

3 Nov 2015

HealthSouth acquires home health and hospice agency operations of CareSouth Health System

HealthSouth Corporation, a leading provider of post-acute healthcare services, today announced its Encompass Home Health business unit has completed its previously announced acquisition of the home health and hospice agency operations of CareSouth Health System, Inc.

2 Nov 2015

Xcelience announces grand opening of new headquarters in Tampa

Xcelience is proud to announce the grand opening of its new 71,000 square foot headquarters located at 4910 Savarese Circle in Tampa. The building houses preformulation and formulation development labs and suites, as well as analytical and stability services. The official ribbon cutting ceremony was attended by Florida Governor Rick Scott, Tampa Mayor Bob Buckhorn and other elected and non-elected officials.

31 Oct 2015

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Alexza Pharmaceuticals, Inc. announced today that it plans to reacquire the U.S. rights for ADASUVE (loxapine) inhalation powder from Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., with an estimated target completion date of January 1, 2016.

31 Oct 2015

Q BioMed signs definitive license agreement with Mannin Research

Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.

30 Oct 2015

Semler Scientific's revenue up 74% in third quarter 2015

Semler Scientific, Inc., a company that provides diagnostic and testing services to healthcare insurers and physician groups, today reported financial results for the third quarter ended September 30, 2015.

30 Oct 2015

Omnicell's revenue increases 11.0% to $125.2 million in Q3 2015

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced results for its third quarter ended September 30, 2015.

From Omnicell, Inc. 30 Oct 2015

Omnicell signs definitive agreement to acquire Aesynt

Omnicell, Inc., a leading provider of medication and supply management solutions to healthcare systems, today announced it has entered into a definitive agreement to acquire Aesynt Incorporated.

From Omnicell, Inc. 30 Oct 2015

Tandem Diabetes Care sales grow 16% to $15.7 million in third quarter 2015

Tandem Diabetes Care, Inc., a medical device company and manufacturer of the t:slim, t:flex and t:slim G4 Insulin Pumps, today reported its financial results for the quarter ended September 30, 2015.

30 Oct 2015

Ultragenyx, Arcturus sign agreement to develop mRNA therapeutics to certain rare diseases

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Arcturus Therapeutics, Inc., a leading RNA medicines company, today announced that they have entered into a research collaboration and license agreement to discover and develop messenger RNA (mRNA) therapeutics to certain rare disease targets using Arcturus' UNA Oligomer chemistry and LUNAR nanoparticle delivery platform.

29 Oct 2015

InComm, Pursuant Health partner to promote health risk assessments in Walmart stores

InComm, a leading prepaid product and transaction services company, and Pursuant Health (formerly SoloHealth) announced today a partnership to allow health plans to promote health risk assessments (HRAs) at Pursuant Health kiosks in Walmart stores. Health plans will be able to issue their members branded incentive cards with healthy rewards as part of the completion of the HRA.

27 Oct 2015

Galil Medical signs agreement to acquire 100% of Perseon

Galil Medical, the global leader in interventional oncology cryoablation technology, announced today it has entered into an agreement to acquire 100% of Perseon Corporation, a publicly-traded company and a leader in the field of microwave ablation, in an all cash transaction valued at $10.6M. The resulting combined company will be privately owned.

27 Oct 2015

Business / Finance

Medigus announces CMS’ publication of fee schedules for endoscopic fundoplication procedures under CPT code 43210 effective January 2016

Denator forms a new Scientific Advisory Board

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Digital health startup boot camp expands to US

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

Addus HomeCare’s net service revenues increase 3.3% to $84.3 million in Q3 2015

HealthSouth acquires home health and hospice agency operations of CareSouth Health System

Xcelience announces grand opening of new headquarters in Tampa

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Q BioMed signs definitive license agreement with Mannin Research

Semler Scientific's revenue up 74% in third quarter 2015

Omnicell's revenue increases 11.0% to $125.2 million in Q3 2015

Omnicell signs definitive agreement to acquire Aesynt

Tandem Diabetes Care sales grow 16% to $15.7 million in third quarter 2015

Ultragenyx, Arcturus sign agreement to develop mRNA therapeutics to certain rare diseases

InComm, Pursuant Health partner to promote health risk assessments in Walmart stores

Galil Medical signs agreement to acquire 100% of Perseon

Ipsen, EpiVax partner to create next generation botulinum neurotoxin and TSI therapeutics

Edwards Lifesciences' net sales grow 1.3% to $615.5 million in third quarter 2015

CareFusion, AAM Healthcare sign exclusive distribution agreement for APA video laryngoscope

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News